Burning Share Price

Burning Share Price

NASDAQ: BNR | Others
$13.23
+$13.23 (--%) Last updated on 21 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Burning Stock Performance

Open
$12.64
Prev. Close
N/A
Circuit Range
N/A
Day Range
$11.11 - $13.25
Year Range
$6.98 - $41.09
Volume
960
Average Traded
$12.53

Burning Share Price Chart

Line chart of the Burning price trend over the selected period. The price rose overall, ranging from 11.11 to 13.30, ending at 13.23.
$11.11$13.25
L
Show Current Price
H

Burning Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$77.12B
Return On Equity (TTM)
N/A
Profit Margin
-10.26%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Burning Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$81.65$75.92$70.67$77.12
Net Profit-$140.80-$92.35-$47.49-$7.91
Net Profit Margin-172.44%-121.64%-67.20%-10.26%
Income ChangeN/A34.41%48.58%83.34%

Burning Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets11.6914.8922.0247.65
Current Assets105.57106.4124.9182.49
Total Assets117.26121.29146.92230.14
Non Current Liabilities5.455.231.162.56
Current Liabilities35.336.4837.2159.65
Total Liabilities40.7541.7138.3762.21
Shareholders' Equity76.5179.58108.55167.93

Burning Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-4.07-12.64-36.13-66.22
Investing-0.63-0.6-1.31-1.08
Financing0.27-0.01-6.9-12.5

Corporate Actions

Split
Ex-date: 15 May 2024

About Burning

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Burning Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.86
$11.11
+4.56%
Oct 2026
$16.10
$10.63
-43.32%
Sep 2026
$9.43
$18.75
+105.09%
Aug 2026
$10.87
$9.14
-16.76%
Jul 2026
$10.07
$10.98
+36.23%
Jun 2026
$8.93
$8.06
-33.00%
May 2026
$17.09
$12.03
-27.38%
Apr 2026
$16.89
$16.57
+1.63%
Mar 2026
$21.16
$16.30
-33.25%
Feb 2026
$35.61
$24.42
-27.61%
Jan 2026
$20.00
$33.73
+64.60%
Dec 2025
$22.12
$20.50
-4.85%

Burning Share Price FAQs